Drug Profile
5-Fluoropyrimidinone
Alternative Names: 5-FPLatest Information Update: 16 Nov 2006
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; SuperGen
- Class Antineoplastics
- Mechanism of Action Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 22 Jul 1997 Phase-I clinical trials for Solid tumours in USA (PO)
- 26 Feb 1996 Preclinical development for Cancer in USA (PO)